primer recognition of a sequence in the third exon (unique to the B27-allele), was used for screening of 270 characterized blood samples, 57 of which were B27-positive. The method proved to be both sensitive and specific:
It unambiguously identified all B27-positive samples and produced no false-positive results. For -1 % of the samples, we had to repeat DNA isolation and PCR to obtain a clear control amplification signal. In contrast to the specificity of the PCR method, parallelperformed flow cytometry gave ambiguous results in 3% of the samples because of antibody cross-reactivity. Flow cytometry and the PCR method described were similar in labor and costs. Therefore, we conclude that the proposed single-step PCR is feasible in a routine laboratory and would improve the reliability of HLA-B27
typing.
Indexing Terms: histocompatibility/flow cytometiy compared! rheumatic disorders
Class I major histocompatibility complex antigens of the human leukocyte antigen (HLA) system include HLA-A, -B, and -C proteins, which are found on most nucleated cells and thrombocytes (1 ) 2 The encoding genes, predominantly located on chromosome 6, show a high degree of allelic polymorphism, with >100 class I alleles described to date. Several HLA allotypes appear to be linked to various diseases.
The most frequently requested typing of a disease-correlated HLA allele is that of HLA-B27.
This allele, present in 9% of the Caucasian population, is strongly associated with the occurrence of several rheumatic diseases, e.g., ankylosing spondylitis, Reiter syndrome, and acute anterior uveitis (1).
Conventional HLA-B27 typing is based on the detection of the HLA antigens at the cellular surface, either by cell cytotoxicity tests (2) (13) , it is based on specific primer recognition of a sequence in the third exon that is unique to the B27-allele.
The aim of our study was to test the feasibility and reliability of this single-step B27-specific exon-3 PCR assay for typing HLA-B27 in a routine laboratory setting. For this purpose, 130 blood samples fully typed for HLA class I were analyzed by the B27-specific exon-3 PCR. For confirmation, a group-specific PCR was performed on exon 2 as described by Yoshida et al. (9) , followed by hybridization with an oligonucleotide probe specific for HLA-B27. In addition, we compared the suitability and cost-effectiveness of carrying out PCR-based genotyping in daily practice with our routine flow-cytometric procedure for 140 blood samples.
Materials and Methods
Preparation of DNA Samples As an internal control procedure for exon-3 amplification, we used 0.1 mol/L -globin primers KM29 (5'-GGVI'GGCCAATCTACTCCCAGG-3') and R842 (5'-GCTCACTCAGTGTG3CAAAG-3'), according to Saiki et al. (15) , as a second primer set. All primers and probes described here were synthesized by Pharmacia Biotech, Woerden, The Netherlands.
HLA-B-specific exon-2 PCR. HLA-B-specific exon-2 PCR was carried out essentially as described for exon-3. The exon-2 primers CG5 (5'-GACGACACGCT-GVPCGTGA-3'), CG2 (5'-GCTCTGGTI'GTAGTAGCG-GA-3'), and CG3 (5'-CTCTGGTTGTAGTAGCCGC-3') were as described by Yoshida et al. (9) . The primer set CG5 X CG2 was designed to specifically amplify a 180-bp fragment of the alleles of the HLA Bw4-group; the other set (CG5 x CG3) was designed to amplify the same fragment in the alleles of the lILA Bw6-group. Together, the two primer sets cover all the known HLA-B alleles except for B54 and B4401 (4, 9) . Consequently, each sample should give a positive result in at least one of these HLA-B exon-2 PCRs. All primer concentrations for exon-2 PCR were 0.5 mol/L. 
which is specific for the B27 alleles (9) , was hybridized to the Bw4-positive exon-2 PCR products.
The probes were 3'-endlabeled with a mixture (molar ratio 1:10) of biotin- (14) .
Results
Three separate PCR reactions were performed on DNA obtained from 155 blood samples, of which 130 were fully typed for lILA class I (14 were HLA-B27 positive) and 25 selected patients' samples were typed for HLA-B27 by flow cytometry (20 were HLA-B27 positive).
The three PCRs included the B27-specific exon-3 PCR to be validated and two group-specific PCRs on exon-2. To confirm the amplification specificity of the exon-3 PCR, we subjected its products to dot-blot hybridization with the B27-specific oligonucleotide probe Cl-7. The two exon-2 PCRs, of which at least one should be positive, assured that the samples actually supported PCR amplification and, in combination with hybridization with a specific probe, further confirmed the presence or absence of HLA-B27 alleles (Fig. 1) .
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